Free Security Reports
Eli Lilly and
Eli Lilly and Company is a global biopharmaceutical firm focused on discovering, developing, and manufacturing medicines that advance patient care. Founded in 1876 and headquartered in Indianapolis, Lilly’s portfolio spans diabetes and obesity, oncology, immunology, neuroscience, and other therapeutic areas. The company invests heavily in R&D, late?stage trials, and biologics manufacturing capacity to meet demand for innovative therapies. Lilly also collaborates with research institutions and biotech partners to accelerate pipelines and expand indications. In commercial markets, the company supports access initiatives, real?world evidence generation, and digital engagement with patients and providers. As of 2024, Lilly employed roughly 47,000 people globally and continued to scale production and supply chains to support growth. Eli Lilly and Company delivers services and products across multiple industries, with a focus on innovation, customer needs, and regulatory compliance. The company engages in strategy development, technological advancement, and partnerships with a wide client base. Through investments in research, infrastructure, and employee development, Eli Lilly and Company supports long-term growth. The company’s portfolio spans solutions that address complex demands in an evolving global landscape. As part of its mission, Eli Lilly and Company emphasizes sustainable practices, ethical governance, and resilience. In addition, Eli Lilly and Company has implemented systems to manage risk, security, and operational efficiency.
Eli Lilly and Certifications and Compliance
Through Panorays’ Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status
Eli Lilly and Cyber Related News
#0
Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.
No relevant cyber news available at this time.
Eli Lilly and External Attack Surface Geolocation Map
Gain detailed insights into the location of your assets through our comprehensive external assessments.
Eli Lilly and Supply Chain Discovery
Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.
Eli Lilly and Cyber Posture Rating
Eli Lilly and security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for Eli Lilly and.
Is this your company? Claim your security score now.
Eli Lilly and Category Breakdown
Human
- Employee
- Security Team
- Social Posture
- Dynamics
Application
- Techs
- Application Security
- Domain Attacks
- Exposed Services
IT
- DNS
- Mail Server
- Asset Reputation
- Web Server
- TLS
- Cloud
- Endpoint

Panorays is a Leader
“Panorays stands out with one of the most ambitious roadmaps and innovation driven approaches to agentic AI in this evaluation…”
Read More Security Reports
-

Jane Street
-

Apex Systems
-

Kinder Morgan